Literature DB >> 8865181

Description of a symptomless cystic fibrosis L346P/M348K compound heterozygous Cypriot individual.

C C Deltas1, K Boteva, A Georgiou, E Papageorgiou, C Georgiou.   

Abstract

During the past few years we have been testing the hypothesis that Cyprus may have been spared many severe cystic fibrosis (CF) cases but not cystic fibrosis transmembrane conductance regulator (CFTR) mutations. We have been analysing by molecular methods patients with atypical mild phenotypes where CF enters the differential diagnosis. With this approach we identified a mutation, L346P, which in association with the severe mutation delta F508 or 1677delTA, confers a mild and atypical presentation. Recently, we identified another entirely symptomless 48-year-old individual, with genotype L346P/M348K. The fact that M348K was initially identified in a severely affected Italian patient strengthens the hypothesis that L346P, a putative mild mutation, is dominant over severe ones. One other explanation is that M348K is not a causative defect but a rare polymorphism. These findings have important implications for genetic counselling, especially when the counselling is sought by concerned couples for prenatal diagnostic purposes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8865181     DOI: 10.1006/mcpr.1996.0042

Source DB:  PubMed          Journal:  Mol Cell Probes        ISSN: 0890-8508            Impact factor:   2.365


  2 in total

1.  Homozygous CFTR mutation M348K in a boy with respiratory symptoms and failure to thrive. Disease-causing mutation or benign alteration?

Authors:  Julia Hentschel; Gabriele Riesener; Heike Nelle; Manfred Stuhrmann; Anja Schöner; Olaf Sommerburg; Eva Fritzsching; Marcus A Mall; Ferdinand von Eggeling; Jochen G Mainz
Journal:  Eur J Pediatr       Date:  2012-01-25       Impact factor: 3.183

2.  Incidental Finding of a Homozygous p.M348K Asymptomatic Italian Patient Confirms the Many Faces of Cystic Fibrosis.

Authors:  Rossana Molinario; Sara Palumbo; Paola Concolino; Sandro Rocchetti; Roberta Rizza; Giovanni Luca Scaglione; Angelo Minucci; Ettore Capoluongo
Journal:  Case Rep Genet       Date:  2015-04-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.